Mentioned in

References in periodicals archive

The precise molecular steps that enable pancreatic cancer to spread to the liver--the event that makes the most-common form of the disease lethal--have been illuminated by an international team led by Weill Cornell Medical College, New York.

How Pancreatic Cancer Spreads to the Liver

The first study is a phase one clinical trial of CPI-613, a drug developed by Raphael Pharmaceuticals that, when used in combination with two other cancer drugs Gemcitabine and Nab-Paclitaxel, produced by Raphael can increase survival rates for patients with advanced or metastatic pancreatic cancer who have not undergone chemotherapy.

Atlantic Health chosen for clinical trials of pancreatic cancer meds

"The endocrinopathies associated with type 2 diabetes mellitus and pancreatic cancer are distinct, the former represented by an increase in glucagon and the latter characterized by a reduction in islet size," said Sajan Nagpal, MD, of the Mayo Clinic in Rochester, Minn., at Digestive Disease Week 2018.

Pancreatopathy of pancreatic cancer distinct from that of T2DM

Patients diagnosed with pancreatic cancer can develop elevated blood sugar levels up to three years before their cancer diagnosis.

Study finds method to detect cancer in diabetic patients

- Results of a study funded by the Woodbury, New York-based pancreatic research funding organization Lustgarten Foundation and the Hale Center for Pancreatic Cancer Research at Dana-Farber Cancer Institute has been published in Cancer Discovery, the organization said.

Lustgarten-Funded Research Shows Benefit of Genetic Sequencing in Advanced Pancreatic Cancer

More than half - 52.3 per cent - of pancreatic cancer cases among diabetics are in those who have been diagnosed less than three years before their cancer diagnosis.

Diabetes in middle age a sign of pancreatic cancer - study

Analysis by the charity Pancreatic Cancer UK found that only 34% of people with pancreatic cancer will receive some kind of surgery, chemotherapy or radiotherapy.

Only one in three pancreatic cancers patients offered treatment

Pancreatic cancer research company The Lustgarten Foundation on Monday announced USD22m in funding in aid of pancreatic cancer research programmes in 2017.

Lustgarten Foundation secures USD22m for pancreatic cancer research programme

"Pancreatic cancer is a terrible disease with no effective screening right now," said Dr.

Finally a Practical Use for Selfies: Screening for Cancer

The 36-year-old, from Cambuslang, near Glasgow, is now development manager with Pancreatic Cancer Scotland, where she has worked since March this year.

I'm glad I followed my heart; Fiona explains why she switched careers to work for cancer charity